Fig. 2From: The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitorsCumulative risk curve of incident atrial fibrillation (AF) for the study cohorts treated with SGTL2i versus DPP4i before and after inverse probability of treatment weights (IPTW). SGLT2i showed a significantly lower cumulative risk of new-onset AF compared with DPP4i in T2DM patients before and after IPTW. aHR = adjusted hazard ratio; CI = confidential interval; IPTW = inverse probability of treatment weights. Other abbreviations as in Fig. 1Back to article page